Human HBEGF/DTR/DTS ORF/cDNA clone-Lentivirus plasmid (NM_001945)
Cat. No.: pGMLP000457
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days
Pre-made Human HBEGF/DTR/DTS Lentiviral expression plasmid for HBEGF lentivirus packaging, HBEGF lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.
Our GM-Lentiviral vector is seamlessly integrated with the GM lentivirus packaging system. Discover more about the GM lentivirus packaging system.
Go to
HBEGF/DTR products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product Description
| Catalog ID | pGMLP000457 |
| Gene Name | HBEGF |
| Accession Number | NM_001945 |
| Gene ID | 1839 |
| Species | Human |
| Product Type | Lentivirus plasmid (overexpression) |
| Insert Length | 627 bp |
| Gene Alias | DTR,DTS,DTSF,HEGFL |
| Fluorescent Reporter | ZsGreen |
| Mammalian Cell Selection | Puromyocin |
| Fusion Tag | 3xflag (C-Terminal) |
| Promoter | CMV |
| Resistance | Amplicin |
| ORF Nucleotide Sequence | ATGAAGCTGCTGCCGTCGGTGGTGCTGAAGCTCTTTCTGGCTGCAGTTCTCTCGGCACTGGTGACTGGCGAGAGCCTGGAGCGGCTTCGGAGAGGGCTAGCTGCTGGAACCAGCAACCCGGACCCTCCCACTGTATCCACGGACCAGCTGCTACCCCTAGGAGGCGGCCGGGACCGGAAAGTCCGTGACTTGCAAGAGGCAGATCTGGACCTTTTGAGAGTCACTTTATCCTCCAAGCCACAAGCACTGGCCACACCAAACAAGGAGGAGCACGGGAAAAGAAAGAAGAAAGGCAAGGGGCTAGGGAAGAAGAGGGACCCATGTCTTCGGAAATACAAGGACTTCTGCATCCATGGAGAATGCAAATATGTGAAGGAGCTCCGGGCTCCCTCCTGCATCTGCCACCCGGGTTACCATGGAGAGAGGTGTCATGGGCTGAGCCTCCCAGTGGAAAATCGCTTATATACCTATGACCACACAACCATCCTGGCCGTGGTGGCTGTGGTGCTGTCATCTGTCTGTCTGCTGGTCATCGTGGGGCTTCTCATGTTTAGGTACCATAGGAGAGGAGGTTATGATGTGGAAAATGAAGAGAAAGTGAAGTTGGGCATGACTAATTCCCACTGA |
| ORF Protein Sequence | MKLLPSVVLKLFLAAVLSALVTGESLERLRRGLAAGTSNPDPPTVSTDQLLPLGGGRDRKVRDLQEADLDLLRVTLSSKPQALATPNKEEHGKRKKKGKGLGKKRDPCLRKYKDFCIHGECKYVKELRAPSCICHPGYHGERCHGLSLPVENRLYTYDHTTILAVVAVVLSSVCLLVIVGLLMFRYHRRGGYDVENEEKVKLGMTNSH |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
| Category | Cat No. | Products Name |
|---|---|---|
| Target Antibody | GM-Tg-g-T76093-Ab | Anti-HBEGF/ DTR/ DTS monoclonal antibody |
| Target Antigen | GM-Tg-g-T76093-Ag | HBEGF VLP (virus-like particle) |
| ORF Viral Vector | pGMLP000457 | Human HBEGF Lentivirus plasmid |
| ORF Viral Vector | pGMAP000278 | Human HBEGF Adenovirus plasmid |
| ORF Viral Vector | vGMLP000457 | Human HBEGF Lentivirus particle |
| ORF Viral Vector | vGMAP000278 | Human HBEGF Adenovirus particle |
Target information
| Target ID | GM-T76093 |
| Target Name | HBEGF |
|
Gene Group Identifier (Target Gene ID in Homo species) |
1839 |
| Gene ID |
100629956 (Equus caballus), 101093578 (Felis catus), 15200 (Mus musculus), 1839 (Homo sapiens) 25433 (Rattus norvegicus), 522921 (Bos taurus), 607007 (Canis lupus familiaris), 695559 (Macaca mulatta) |
| Gene Symbols & Synonyms | HBEGF,Hbegf,Dtr,Dts,Hegfl,DTR,DTS,DTSF,HEGFL,GFHB,Hb-egf,HB-EGF |
| Target Alternative Names | DTR,DTS,DTSF,Dtr,Dts,GFHB,HB-EGF,HBEGF,HEGFL,Hb-egf,Hbegf,Hegfl,Proheparin-binding EGF-like growth factor |
| Uniprot Accession |
Q06175,Q06186,Q99075
Additional SwissProt Accessions: Q06186,Q99075,Q06175 |
| Uniprot Entry Name | |
| Protein Sub-location | Transmembrane Protein |
| Category | Therapeutics Target |
| Disease | cancer, Urinary Tract Infection, Overactive bladder |
| Disease from KEGG | Endocrine resistance, ErbB signaling pathway, GnRH signaling pathway, Parathyroid hormone synthesis, secretion and action, Epithelial cell signaling in Helicobacter pylori infection, Proteoglycans in cancer, Bladder cancer |
| Gene Ensembl | ENSMUSG00000024486, ENSG00000113070, ENSBTAG00000021766, ENSCAFG00845001249, ENSMMUG00000060742 |
| Target Classification |
About GMVC

GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.


